SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-051733
Filing Date
2023-10-03
Accepted
2023-10-03 19:21:18
Documents
1
Period of Report
2023-09-29

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10409
  Complete submission text file 0000950170-23-051733.txt   11726
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 376 MANHATTAN AVENUE APT. 3 BROOKLYN NY 11211
Business Address
Aziz Kabeer (Reporting) CIK: 0001914847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 231306111